Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and post-operative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels

Journal of Endocrinological Investigation

Volumn 29, Issue 5, 2006, Pages 443-449

  Benit, A ^a   Allard, J ^a   Rimailho, J ^a   Fauvel, J ^b   Escourrou, G ^c   Vezzosi, D ^a   Donadille, F ^a   Bennet, A ^a   Caron, P ^a  

^a CHU RANGUEIL   (France)

^b Serv Univ Psychiat l'Enfant l'A   (France)

^c CHU PURPAN   (France)

Author keywords

Hypercalcemia; Ovarian carcinoma; PTH rP; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; CARBOPLATIN; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN;

AGED; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CANCER STAGING; CASE REPORT; CLEAR CELL CARCINOMA; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HYPERCALCEMIA; HYSTERECTOMY; INTRAOPERATIVE PERIOD; OVARIAN VEIN; OVARY CARCINOMA; PARATHYROID HORMONE BLOOD LEVEL; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; SALPINGOOOPHORECTOMY; VITAMIN BLOOD LEVEL;

EID: 33745889593     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344128     Document Type: Article

References (48)

1. Strewler GJ. Humoral manifestation of malignancy. In: Larsen PR, Kronenberg HM, Melmed S, KS Polonsky KS eds. Williams Textbook of Endocrinology. 10th ed. Philadelphia: Saunders. 2003, 1834-6.
2. Kremer R, Goltzman D. Hypercalcemia due to PTHrP. In: Bilezikian JP, Marcus R, Levine MA eds. The Parathyroids. Basic and clinical concepts. 2nd ed. San Diego: Academic Press. 2001, 671-89.
3. Strewler GJ. The parathyroid hormone-related protein. Hormones and disorders of mineral metabolism. Endocrinol Metab Clin North Am 2000, 29: 629-45.
4. Holtz G. Paraneoplastic hypercalcemia in gynecologic malignancy. Obstet Gynecol Surv 1980, 35: 129-36.
5. Ferenczy A, Okagaki T, Richart RM. Para-endocrine hypercalcemia in ovarian neoplasms. Cancer 1971, 27: 427-33.
6. Fujino T, Watanabe T, Yamaguchi K, et al. The development of hypercalcemia in a patient with an ovarian tumor producing parathyroid hormone-related protein. Cancer 1992, 70: 2845-50.
7. Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 1990, 112: 499-504.
8. Sato K, Fujii Y, Czawa M. Parathyroid hormone-related protein and interleukin 1α synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo. Endocrinology 1989, 124: 2172-8.
9. Adams JS, Fernandez M, Gacad MA, et al. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood 1989, 73: 235-9.
10. Seymour JF, Gagel RF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood 1993, 82: 1383-94.
11. Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med 1994, 121: 633-40.
12. Wong KF, Chan JK, Ma SK, Chu YC. Megakaryoblastic transformation of polycythemia vera associated with hypercalcemia. Am J Hematol 1993, 43: 240-2.
13. Strewler GJ, Budayr AA, Clark OH, Nissenson RA. Production of parathyroid hormone by a malignant nonparathyroid tumor in a hypercalcemic patient. J Clin Endocrinol Metab 1993, 76: 1373-5.
14. Yoshimoto K, Yamasaki R, Sakai H, et al. Ectopic production of parathyroid hormone by small cell lung cancer in a patient with hypercalcemia. J Clin Endocrinol Metab 1989, 68: 976-81.
15. Rizzoli R, Pache JC, Didierjean L, Burger A, Bonjour JP. A thymoma as a cause of true ectopic hyperparathyroidism. J Clin Endocrinol Metab 1994, 79: 912-5.
16. Ohira S, Itoh K, Shiozawa T, et al. Ovarian non-small cell neuroendocrine carcinoma with paraneoplastic parathyroid hormone related hypercalcemia. Int J Gynecol Pathol 2004, 23: 393-7.
17. Nussbaum SR, Gaz RD, Arnold A. Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone. N Engl J Med 1990, 323: 1324-8.
18. Wysolmerski JJ, Broadus AE. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein. Ann Rev Med 1994, 45: 189-200.
19. Knecht T, Behling C, Burton D, Glass C, Deftos L. The humoral hypercalcemia of benignancy, a newly appreciated syndrome. Am J Clin Pathol 1996, 105: 487-92.
20. Bilici A, Doventas A, Karadag B, Hekim N, Tezcan V. Hypercalcemia associated with a uterine leiomyoma: a case report and review of the literature. Gynecol Oncol 2004, 93: 269-71.
21. Khosla S, Van Heerden JA, Gharib H, et al. Parathyroid hormone-related protein and hypercalcemia secondary to massive mammary hyperplasia. N Engl J Med 1990, 322: 1157.
22. Stewart AF, Hoeckler JL, Mallette LE, Segre GV, Amatruda TT, Vignery A. Hypercalcemia in pheochromocytoma: Evidence for a novel mechanism. Ann Intern Med 1985, 102: 776-9.
23. Kimura S, Nishimura Y, Yamaguchi K, Nagasaki K, Shimada K, Uchida H. A case of pheochromocytoma producing parathyroid hormone-related protein and presenting with hypercalcemia. J Clin Endocrinol Metab 1990, 70: 1559-63.
24. Braude S, Graham A, Mitchell D. Lymphoedema/hypercalcemia syndrome mediated by parathyroid hormone-related protein. Lancet 1991, 337: 140-1.
25. Asa S, Henderson J, Goltzman D, Drucker D. Parathyroid hormone-like peptide in Normal and Neoplastic Human Endocrine Tissues. J Clin Endocrinol Metab 1990, 71: 1112-8.
26. Garmey JC, Schnorr JA, Bruns ME, et al. Expression of PTH-rP and its receptor in the porcine ovary: regulation by transforming growth factor-beta and possible paracrine effects of granulosa cell PTH-rP secretion on the theca cells. Biol Reprod 2000, 62: 334-9.
27. Morimoto T, Devora GA, Mibe M, Casey ML, MacDonald PC. Parathyroid hormone-related protein and human myometrial cells: action and regulation. Mol Cell Endocrinol 1997, 129: 91-9.
28. Hoekman K, Tjandra YI, Papapoulos SE. The role of 1,25-dihydroxyvitamin D in the maintenance of hypercalcemia in a patient with an ovarian carcinoma producing parathyroid hormone-related protein. Cancer 1991, 68: 642-7.
29. Takeuchi K, Murata K, Funaki K, Kitazawa S, Kitazawa R. Immunohistochemical detection of parathyroid hormone-related protein in a squamous cell carcinoma arising from mature cystic teratoma causing humoral hypercalcemia of malignancy. Gynecol Oncol 2000, 79: 504-7.
30. Tsunematsu R, Saito T, Iguchi H, Fukuda T, Tsukamoto N. Hypercalcemia due to the parathyroid hormone-related protein produced by primary ovarian clear cell adenocarcinoma: case report. Gynecol Oncol 2000, 7: 218-22.
31. Matias-Guiu X, Prat J, Young RH, et al. Human parathyroid hormone-related protein in ovarian small cell carcinoma. An immunohistochemical study. Cancer 1994, 73: 1878-81.
32. Koshiyama M, Fujii H, Konishi M, et al. Recurrent clear cell carcinoma of the ovary changing into producing parathyroid hormone-related protein (PTH-rP) with hypercalcemia. Eur J Obstet Gynecol Reprod Biol 1999, 82: 227-9.
33. Kitazawa R, Kitazawa S, Matui T, Maeda S. In situ detection of parathyroid hormone-related protein in ovarian clear cell carcinoma. Hum Pathol 1997, 28: 379-82.
34. McCluggage WG, Oliva E, Connolly LE, McBride HA, Young RH. An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 2004, 23: 330-6.
35. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 1980, 303: 1377-81
36. Budayr AA, Zysset E, Jenzer A, et al. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein. J Bone Min Res 1994, 9: 521-6.
37. Strewler GJ, Wronsli TJ, Halloran BF, et al. Pathogenesis of hypercalcemia in nude mice bearing a human renal carcinoma. Endocrinology 1986, 119: 303-10.
38. Horiuchi N, Caulfield MP, Fisher JE, et al. Similarity of synthetic peptide from human tumor to parathyroid hormone in vivo and in vitro. Science 1987, 238: 1566-8.
39. Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocana A, Stewart AF. Direct comparison of sustained infusion of human parathyroid hormone related protein (1-36) versus hPTH (1-34) on serum calcium, plasma 1, 25-dihydroxyvitamin D concentrations, and fractionnal calcium excretion in healthy human volonteers. J Clin Endocrinol Metab 2003, 88: 1603-9.
40. Evans KN, Taylor H, Zehnder D, et al. Increased expression of 25-hydroxyvitamin D-1 alpha-hydroxylase in dysgerminomas: a novel form of humoral hypercalcemia of malignancy. Am J Pathol 2004, 165: 807-13.
41. Michigami T, Yamoto H, Suzuki H, Nagai-Itagaki Y, Sato K, Ozono K. Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D3-1 alphahydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy. J Endocrinol 2001, 171: 249-57.
42. Hulter HN, Halloran BP, Toto RD, Peterson JC. Long-term control of plasma calcitriol concentration in dogs and humans. Dominant role of plasma calcium concentration in experimental hyperparathyroidism. J Clin Invest 1985, 76: 695-702.
43. Fukumoto S, Matsumoto T, Yamoto H, et al. Suppression of serum 1,25-dihydroxyvitamin D in humoral hypercalcemia of malignancy is caused by elaboration of a factor that inhibits renal 1,25-dihydroxyvitamin D3 production. Endocrinology 1989, 124: 2057-62.
44. Rizvi AA, Bowman MA, Vaughters RB 3rd, Isales C, Mulloy AL. Primary ovarian lymphoma manifesting with severe hypercalcemia. Endocr Pract 2003, 9: 389-93.
45. Grill V, Murray RM, Ho PW, et al. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD). J Clin Endocrinol Metab 1992, 74: 1468-70.
46. Wimalawansa SJ. Significance of plasma PTHrP in patients with hypercalcemia of malignancy treated with biphosphinate. Cancer 1994, 73: 2223-30.
47. Pecherstorfer M, Schilling T, Blind E, et al. Parathyroid hormone related protein and life expectancy in hypercalcemic cancer patients. J Clin Endocrinol Metab 1994, 78: 1268-70.
48. Truong UN, Papavasiliou V, Goltzman D, Kremer R. Parathyroid hormone related peptide (PTHRP) is a prognostic indicator in hypercalcemic cancer patients with skeletal or extra skeletal metastasis. J Bone Min Res 1999, 14: S189.